Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
As Mapp's products transition to clinical evaluation, licenses are transferred to Mapp's commercialization partner, LeafBio.
August 12, 2014 at 8:30 AM - The available supply of ZMapp™ has been exhausted. We have complied with every request for ZMapp™ that had the necessary legal/regulatory authorization. It is the requestors’ decision whether they wish to make public their request, acquisition, or use of the experimental drug. Any decision to use ZMapp™ must be made by the patients’ medical team. Drug has been provided at no cost in all cases.
Mapp Biopharmaceutical, Inc.
6160 Lusk Blvd. # C105
San Diego, CA 92121
phone: 858 625 0335
fax: 800 372 2176
|©2012 Mapp Biopharmaceutical, Inc. All rights reserved.|